Quantcast
Last updated on April 23, 2014 at 20:10 EDT

Latest Bone density Stories

2010-10-08 14:54:32

Ultrasound can speed the healing of fractures. A randomized controlled trial reported in the open access journal BMC Musculoskeletal Disorders has found that the use of low-intensity pulsed ultrasound (LIPUS) in patients with tibial fractures which showed inadequate progress toward healing resulted in 34% greater bone mineral density (BMD) in the fracture area after 16 weeks than use of a sham device. Jon E. Block, Ph.D. worked with a team of researchers from University Hospital Marburg and...

2010-09-22 19:35:32

Advanced imaging for osteoporosis research and materials science A novel nano-tomography method developed by a team of researchers from the Technische Universitaet Muenchen, the Paul Scherrer Institute and the ETH-Zurich opens the door to computed tomography examinations of minute structures at nanometer resolutions. Three-dimensional detailed imaging of fragile bone structures becomes possible. Their first nano-CT images will be published in Nature on Sept. 23, 2010. This new technique will...

2010-09-22 12:56:00

Spanish researchers have confirmed there is a genetic risk factor for osteoporosis and bone fractures. Although more studies are still needed, these findings will make it possible to take preventive measures. Scientists from the University of Barcelona (UB) have discovered that the genetic variant 677C>T (a single nucleotide polymorphism (SNP) that is very well known in genetic studies) is linked to osteoporotic vertebral fractures, which many women suffer from after the menopause. "In...

2010-08-23 13:38:07

A thesis from the University of Gothenburg (Sweden) is the first in Scandinavia to study the occurrence of low bone mineral density in children and teenagers with inflammatory bowel disease. Half of the patients in the study showed signs of low bone mineral density. The results emphasise the importance of treating the underlying inflammatory bowel disease more effectively, and of measuring bone mineral density in this group of patients. Low bone mineral density, or BMD, was evident in around...

2010-07-14 15:34:12

A comprehensive Argentinean epidemiological study reveals the staggering costs of osteoporosis in the country. The key findings of the article published in April 2010 in the scientific journal "Archives of Osteoporosis", include:"¢ In Argentina, bone mineral density studies reveal that one out of three women aged 50 or over suffers from osteoporosis."¢ The prevalence of vertebral fractures in Argentinean women aged 50 or older is 16%."¢ Over 34.000 hip fractures occur every...

2010-06-28 01:57:00

MUNICH, June 28, 2010 /PRNewswire/ -- - 3D Images Provide New Approach to Monitoring Bone Changes Interim data from a prospective Investigator Initiated Trial (IIT) presented today at the ECTS, the 37th European Symposium on Calcified Tissues, in Glasgow, demonstrates that EVISTA(R) (raloxifene 60mg; once-daily, distributed in 34 countries by DAIICHI SANKYO), indicated for the treatment and prevention of osteoporosis in postmenopausal women, improves bone quality as measured by...

2010-06-17 15:17:10

Italian postmenopausal women who have a low calcium intake show a higher risk of developing both osteoporosis and hypertension (a chronic medical condition in which arterial blood pressure is elevated) than those who consume higher levels of calcium according to research presented today at EULAR 2010, the Annual Congress of the European League Against Rheumatism in Rome, Italy. In this Italian study of 825 postmenopausal women with hypertension, a significantly increased proportion of women...

2010-06-01 17:10:00

THOUSAND OAKS, Calif., June 1 /PRNewswire-FirstCall/ -- Amgen Inc. (Nasdaq: AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Prolia(TM) (denosumab) for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy. Prolia, the first and only FDA-approved RANK...

2010-06-01 16:21:00

SILVER SPRING, Md., June 1 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Prolia, an injectable treatment for postmenopausal women with osteoporosis who are at high risk for fractures. (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) Osteoporosis is a disease in which the bones become weak and are more likely to break. According to the National Institute of Arthritis and Musculoskeletal and Skin Diseases, 80 percent of the people in the...

2010-05-28 03:34:00

THOUSAND OAKS, Calif., May 28 /PRNewswire-FirstCall/ -- Amgen Inc. (Nasdaq: AMGN) today announced that the European Commission (EC) has granted marketing authorization for Prolia® (denosumab) for the treatment of osteoporosis in postmenopausal women at increased risk of fractures, and for the treatment of bone loss associated with hormone ablation in men with prostate cancer at increased risk of fractures. Prolia has been approved in all 27 European Union member states...